Skip to content

Pulsar-18 T3 4/120/135Recalls & reported problems

Biotronik AG · Class 3 · Implant

All models of Pulsar-18 T3 (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07640130446816), received between Mar 12, 2024 and Mar 12, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Difficult or Delayed Activation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult or Delayed Activation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 12, 2024Difficult or Delayed Activation; Difficult or Delayed Activation

    A PULSAR 18 T3 SELF-EXPANDABLE PERIPHERAL ARTERY STENT WAS POSITIONED AT THE LESION SITE. AFTER THE STENT HAD BEEN DEPLOYED 2CM, THE DEPLOYMENT WHEEL TURNED IN A VACUUM. THE HANDLE WAS EXAMINED, AND IT WAS OBSERVED THAT A METAL WIRE WAS PROTRUDING FROM IT. IT WAS THEREFORE NECESSARY TO DISMANTLE THE HANDLE IN ORDER TO FINALIZE THE DEPLOYMENT OF THE STENT BY CREATING A FIXED WITHDRAWAL POINT. THE STENT WAS FINALLY PROPERLY DEPLOYED, AND NO PART OF THE DEPLOYMENT SHEATH WAS LOST IN THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18890486 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page